Healthcare resource utilization and costs associated with inadequate initial antibiotic treatment of bacteraemia produced by carbapenem-resistant Gram-negative bacilli (CRGNB): a descriptive, observational study in Spanish hospitals.

José Garnacho-Montero, José María Aguado, Enrique Alemparte, Juan P Horcajada, Francisco López-Medrano, Paula Ramírez, Ariadna Giró-Perafita, Martí Blasco, Borja Suberviola
{"title":"Healthcare resource utilization and costs associated with inadequate initial antibiotic treatment of bacteraemia produced by carbapenem-resistant Gram-negative bacilli (CRGNB): a descriptive, observational study in Spanish hospitals.","authors":"José Garnacho-Montero, José María Aguado, Enrique Alemparte, Juan P Horcajada, Francisco López-Medrano, Paula Ramírez, Ariadna Giró-Perafita, Martí Blasco, Borja Suberviola","doi":"10.37201/req/121.2024","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Carbapenem-resistant gram-negative bacilli (CRGNB) are one of the main causes of nosocomial infections, posing a major public health challenge. Blood stream infections (BSI) require special attention because of the higher morbidity and mortality associated.</p><p><strong>Objective: </strong>To assess the impact of initial adequate or inadequate antibiotic treatment on the length of stay (LOS) and healthcare resource utilisation of patients with bloodstream infections (BSI) caused by a Carbapenem-resistant gram-negative bacilli (CRGNB) in the Spanish clinical practice.</p><p><strong>Methods: </strong>A descriptive, observational, retrospective chart review study of patients diagnosed with CRGNB bacteriemia in 6 Spanish public hospitals.</p><p><strong>Results: </strong>The overall median LOS of the total population (n=64) was 26.5 days (Q1: 16 days; Q3: 40 days). The median LOS for the initially adequately treated group was 27 days (Q1: 17; Q3: 50), and 24 days (Q1: 15; Q3: 38) for the initially inadequately treated (t-test p= 0.5031). In the Hospital Ward group (n=44), initially adequately treated patients spent hospitalised a median of 6 days less than the initially inadequately treated patients (18 days [Q1: 12; Q3: 27] vs 24 days [Q1: 15; Q3: 38] respectively, p=0.0269). In the total population analysis, initially adequately treated patients had a lower use of resources (20,895.02 [Q1: 11,543.67 ; Q3: 61,773.17 ]) compared to initially inadequately treated patients (24,444.02 [Q1: 11,571.63 ; Q3: 40,790.64 ).</p><p><strong>Conclusion: </strong>Results suggest that inadequate empirical treatment for BSI caused by CRGNB in the hospital ward could be associated with an increase in the LOS and resource utilization of these patients.</p>","PeriodicalId":94198,"journal":{"name":"Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia","volume":"38 3","pages":"197-207"},"PeriodicalIF":2.2000,"publicationDate":"2025-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12095935/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.37201/req/121.2024","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/25 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Carbapenem-resistant gram-negative bacilli (CRGNB) are one of the main causes of nosocomial infections, posing a major public health challenge. Blood stream infections (BSI) require special attention because of the higher morbidity and mortality associated.

Objective: To assess the impact of initial adequate or inadequate antibiotic treatment on the length of stay (LOS) and healthcare resource utilisation of patients with bloodstream infections (BSI) caused by a Carbapenem-resistant gram-negative bacilli (CRGNB) in the Spanish clinical practice.

Methods: A descriptive, observational, retrospective chart review study of patients diagnosed with CRGNB bacteriemia in 6 Spanish public hospitals.

Results: The overall median LOS of the total population (n=64) was 26.5 days (Q1: 16 days; Q3: 40 days). The median LOS for the initially adequately treated group was 27 days (Q1: 17; Q3: 50), and 24 days (Q1: 15; Q3: 38) for the initially inadequately treated (t-test p= 0.5031). In the Hospital Ward group (n=44), initially adequately treated patients spent hospitalised a median of 6 days less than the initially inadequately treated patients (18 days [Q1: 12; Q3: 27] vs 24 days [Q1: 15; Q3: 38] respectively, p=0.0269). In the total population analysis, initially adequately treated patients had a lower use of resources (20,895.02 [Q1: 11,543.67 ; Q3: 61,773.17 ]) compared to initially inadequately treated patients (24,444.02 [Q1: 11,571.63 ; Q3: 40,790.64 ).

Conclusion: Results suggest that inadequate empirical treatment for BSI caused by CRGNB in the hospital ward could be associated with an increase in the LOS and resource utilization of these patients.

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
对碳青霉烯耐药革兰氏阴性杆菌(CRGNB)产生的菌血症,与初始抗生素治疗不充分相关的医疗资源利用和成本:西班牙医院的一项描述性观察性研究。
碳青霉烯耐药革兰氏阴性杆菌(CRGNB)是医院感染的主要原因之一,对公共卫生构成重大挑战。血流感染(BSI)需要特别关注,因为其相关的发病率和死亡率较高。目的:评估在西班牙临床实践中,最初适当或不适当的抗生素治疗对碳青霉烯耐药革兰氏阴性杆菌(CRGNB)引起的血流感染(BSI)患者的住院时间(LOS)和医疗资源利用的影响。方法:对西班牙6家公立医院诊断为CRGNB菌血症的患者进行描述性、观察性、回顾性图表回顾研究。结果:总人群(n=64)的总中位生存期(LOS)为26.5天(Q1: 16天;Q3: 40天)。初始充分治疗组的中位生存时间为27天(Q1: 17;Q3: 50), 24天(Q1: 15;Q3: 38)对于最初治疗不充分的患者(t检验p= 0.5031)。在医院病房组(n=44),最初接受充分治疗的患者比最初未接受充分治疗的患者住院时间中位数少6天(18天[Q1: 12;Q3: 27天和24天[Q1: 15;Q3: 38], p=0.0269)。在总体人群分析中,最初接受充分治疗的患者资源使用率较低(20,895.02欧元[Q1: 11,543.67欧元;第三季度:61,773.17欧元]),而最初治疗不足的患者(24,444.02欧元[第一季度:11,571.63欧元;第三季度:40,790.64欧元)。结论:结果提示,医院病房CRGNB所致BSI的经验治疗不充分可能与这些患者的LOS和资源利用率增加有关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Intravenous non-specific immunoglobulins as adjunctive therapy for invasive Streptococcus pyogenes infection: an eleven-year retrospective study. [Bacteremia secondary to Campylobacter jejuni pancolitis in an immunocompetent patient]. [Delafloxacin: what does a new fluoroquinolone offer?] Rezafungin for the treatment of invasive candidiasis secondary to esophagogastric anastomotic leak: clinical success in a complex situation. [Diagnosis of an atypical case of infective endocarditis: added value of molecular biology techniques].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1